Infectious Disease and Microbiology - Yersinia enterocolitica Infections

BASICS

Description

Yersinia enterocolitica is a gram-negative coccobacillus that causes gastrointestinal and occasionally systemic infection.

The genus Yersinia includes:

• Yersinia pestis — causes plague

• Yersinia enterocolitica

• Yersinia pseudotuberculosis

Yersinia species are facultative anaerobes.

Y. enterocolitica most commonly causes:

• Acute enterocolitis

• Terminal ileitis

• Mesenteric adenitis

• Enteric fever–like illness

• Septicemia in high-risk patients

• Rare focal extraintestinal infections

⸻

EPIDEMIOLOGY

Y. enterocolitica occurs worldwide.

It has historically been reported more frequently in:

• Northern Europe

• Parts of North America

• South America

• Africa

• Asia

In some European countries, Yersinia has been among the more commonly identified bacterial foodborne pathogens.

Disease is especially common in:

Young children, particularly those younger than 5 years.

Acute enterocolitis is the most frequent clinical presentation in this age group.

⸻

TRANSMISSION

Y. enterocolitica infection is usually acquired through ingestion of contaminated food or water.

Important routes include:

• Contaminated pork

• Undercooked pork products

• Untreated water

• Contaminated food

• Contact with infected animals

• Rarely, contaminated blood products

Pigs are an especially important reservoir.

⸻

ANIMAL RESERVOIRS

Natural reservoirs include:

• Pigs

• Rodents

• Rabbits

• Sheep

• Cattle

• Horses

• Dogs

• Cats

Pork exposure is one of the most important epidemiologic clues.

⸻

RISK FACTORS

Important risk factors include:

• Consumption of raw or undercooked pork

• Exposure to untreated water

• Young age

• Advanced age

Severe or invasive disease is more likely in patients with:

• Iron overload

• Hemochromatosis

• Beta-thalassemia

• Severe anemia

• Cirrhosis

• Diabetes mellitus

• Malignancy

• Immunocompromising conditions

⸻

IRON OVERLOAD — HIGH YIELD

Yersinia has a particularly important relationship with iron.

Patients with excess body iron have a substantially increased risk of severe Y. enterocolitica infection.

Examples include:

• Hemochromatosis

• Thalassemia

• Repeated blood transfusions

⸻

DESFERRIOXAMINE

Patients receiving desferrioxamine, also called deferoxamine, are at particularly high risk for invasive Yersinia infection.

Why?

Yersinia can use iron bound to deferoxamine as a growth-promoting siderophore.

Therefore:

Iron overload + deferoxamine therapy + fever or abdominal symptoms

→ Strongly consider invasive Yersinia infection.

⸻

TRANSFUSION-ASSOCIATED INFECTION

Y. enterocolitica can rarely contaminate stored red blood cell products.

This occurs because the organism can:

• Survive refrigerated temperatures

• Multiply during prolonged blood storage

Transfusion of heavily contaminated blood can cause:

• Acute fever

• Hypotension

• Septic shock

• Hemolysis

• Disseminated intravascular coagulation

This is a rare but important transfusion-associated bacterial infection.

⸻

GENERAL PREVENTION

Prevention focuses on reducing exposure to animal reservoirs and contaminated food.

Important measures include:

• Cook pork thoroughly

• Avoid raw or undercooked pork

• Prevent cross-contamination during food preparation

• Use safe drinking water

• Practice careful hand hygiene

• Wash hands after handling raw pork or animals

• Use appropriate food-processing and slaughtering practices

Blood-storage and transfusion safety measures also help reduce transfusion-associated infection.

⸻

ETIOLOGY

Y. enterocolitica is:

• Gram negative

• Facultatively anaerobic

• Non–lactose fermenting

• Urease positive

It belongs to the family Enterobacterales.

⸻

PATHOPHYSIOLOGY

After oral ingestion, the organism reaches the terminal ileum.

It invades the intestinal mucosa and preferentially localizes in:

Peyer’s patches

The organism then spreads to:

Mesenteric lymph nodes

This explains the characteristic combination of:

• Terminal ileitis

• Mesenteric adenitis

• Right lower quadrant abdominal pain

The presentation may closely resemble acute appendicitis.

⸻

INCUBATION PERIOD

Symptoms usually begin approximately:

4–7 days after exposure

The possible range may be roughly:

1–11 days

⸻

CLINICAL MANIFESTATIONS

Y. enterocolitica produces several important clinical syndromes.

These include:

• Acute enterocolitis

• Terminal ileitis

• Mesenteric adenitis

• Pseudoappendicitis

• Enteric fever–like illness

• Bacteremia/septicemia

• Focal extraintestinal disease

• Postinfectious reactive arthritis

⸻

ACUTE ENTEROCOLITIS

This is the most common presentation.

It occurs particularly in:

Young children.

Symptoms may include:

• Fever

• Diarrhea

• Abdominal pain

• Nausea

• Vomiting

Stools may contain:

• Leukocytes

• Mucus

• Occasionally blood

The diarrhea is usually self-limited.

⸻

PSEUDOAPPENDICITIS

One of the most important clinical associations is:

Yersinia → pseudoappendicitis

Older children and adults may develop:

• Right lower quadrant abdominal pain

• Fever

• Terminal ileitis

• Mesenteric lymphadenitis

This may closely mimic:

Acute appendicitis

A patient may even undergo surgery before the infectious diagnosis becomes apparent.

⸻

MESENTERIC ADENITIS

Yersinia can infect mesenteric lymph nodes and produce:

• Enlarged lymph nodes

• Necrotizing lymphadenitis

• Right lower quadrant abdominal pain

This syndrome is especially associated with:

Y. enterocolitica and Y. pseudotuberculosis.

⸻

TERMINAL ILEITIS

Inflammation of the terminal ileum may resemble:

• Crohn disease

• Appendicitis

• Other inflammatory bowel disorders

Clinical presentation can include:

• Fever

• Abdominal pain

• Diarrhea

• Right lower quadrant tenderness

⸻

ENTERIC FEVER–LIKE ILLNESS

Some patients develop a systemic febrile syndrome characterized by:

• Fever

• Headache

• Abdominal pain

• Malaise

This can resemble typhoid or another systemic enteric infection.

⸻

SEPTICEMIA

Y. enterocolitica bacteremia is uncommon but potentially severe.

It occurs mainly in high-risk patients with:

• Iron overload

• Cirrhosis

• Diabetes

• Malignancy

• Severe anemia

• Immunosuppression

• Very young or advanced age

Clinical manifestations may include:

• High fever

• Hypotension

• Septic shock

• Multiorgan dysfunction

Mortality is substantial in invasive disease.

⸻

EXTRAINTESTINAL INFECTIONS

Rare focal infections may include:

• Abscesses

• Osteomyelitis

• Septic arthritis

• Endocarditis

• Meningitis

• Hepatic infection

These usually occur in patients with major underlying disease or bacteremia.

⸻

PHYSICAL EXAMINATION

There are no pathognomonic examination findings.

Possible findings include:

• Fever

• Abdominal tenderness

• Right lower quadrant tenderness

• Signs of dehydration

• Signs of sepsis in invasive disease

In pseudoappendicitis, the abdominal examination may strongly resemble appendicitis.

⸻

DIAGNOSIS

Diagnosis depends on the clinical syndrome and microbiologic testing.

Possible specimens include:

• Stool

• Blood

• Mesenteric lymph nodes

• Tissue from affected sites

⸻

STOOL CULTURE

Stool culture can identify Y. enterocolitica in patients with enterocolitis.

Because Yersinia is not always recovered on routine culture conditions, the laboratory should be informed when infection is suspected.

Special culture approaches may improve recovery.

Yersinia can grow at low temperatures, a characteristic sometimes exploited using:

Cold enrichment

⸻

STOOL FINDINGS

Possible stool findings include:

• Fecal leukocytes

• Mucus

• Occult or visible blood

Fecal shedding may continue for:

Several weeks after symptoms resolve.

⸻

BLOOD CULTURES

Blood cultures should be obtained when:

• Bacteremia is suspected

• The patient is toxic

• There is hypotension

• Significant comorbidity is present

• There is iron overload

• Transfusion-associated sepsis is suspected

⸻

LYMPH NODE CULTURE

In patients undergoing surgery for presumed appendicitis, culture of:

• Mesenteric lymph nodes

• Terminal ileal tissue

may reveal Yersinia.

⸻

SEROLOGY

Serologic testing can support diagnosis, particularly in selected extraintestinal or postinfectious syndromes.

However:

• It is not routinely available everywhere

• Cross-reactivity occurs

• Interpretation can be difficult

Cross-reactions may occur between:

• Y. enterocolitica

• Y. pseudotuberculosis

• Other bacteria

Agglutinating antibodies usually appear early and decline over several months.

⸻

MOLECULAR TESTING

Modern multiplex gastrointestinal PCR panels may detect Y. enterocolitica directly from stool in some laboratories.

Advantages include:

• Rapid detection

• Greater sensitivity than conventional culture in some settings

However, culture remains useful when:

• Antimicrobial susceptibility testing is required

• Public-health investigation is needed

• Confirmation of invasive disease is important

⸻

DIFFERENTIAL DIAGNOSIS

Depending on presentation, consider:

• Acute appendicitis

• Crohn disease

• Campylobacter enteritis

• Salmonellosis

• Shigellosis

• Enteroinvasive E. coli

• Clostridioides difficile infection

• Mesenteric adenitis from other causes

• Typhoid fever

• Viral gastroenteritis

For right lower quadrant pain:

Yersinia should be remembered as a classic infectious cause of pseudoappendicitis.

⸻

TREATMENT

Most uncomplicated gastrointestinal infections are:

Self-limited

Therefore, antimicrobial treatment is not routinely required for mild uncomplicated enterocolitis.

The most important management is:

• Hydration

• Electrolyte replacement

• Supportive care

⸻

WHEN TO CONSIDER ANTIBIOTICS

Antibiotic treatment is appropriate in:

• Severe enterocolitis

• Complicated gastrointestinal infection

• Bacteremia

• Septicemia

• Extraintestinal infection

• Immunocompromised patients

• Patients with major comorbidities

• Patients with iron overload and systemic disease

⸻

ANTIMICROBIAL OPTIONS

Active agents may include:

• Trimethoprim-sulfamethoxazole

• Fluoroquinolones

• Third-generation cephalosporins

• Doxycycline

• Aminoglycosides in selected severe cases

Choice should be based on:

• Disease severity

• Site of infection

• Susceptibility results

• Patient age

• Pregnancy status

• Local resistance patterns

⸻

SEVERE SEPTICEMIA

For severe invasive infection, regimens may include:

Ceftriaxone

with or without:

Gentamicin

or a fluoroquinolone such as:

Ciprofloxacin

Therapy should be individualized according to susceptibility testing and clinical response.

⸻

UNCOMPLICATED ENTEROCOLITIS

Antibiotics generally provide limited benefit in uncomplicated disease because:

• The illness is usually self-limited

• Symptoms often resolve spontaneously

Therefore:

Mild diarrhea + stable patient

→ Supportive treatment is usually sufficient.

⸻

SUPPORTIVE CARE

Important measures include:

• Oral rehydration

• Intravenous fluids when necessary

• Electrolyte replacement

• Nutritional support

• Antipyretics when appropriate

Severe dehydration or systemic illness may require hospitalization.

⸻

REACTIVE ARTHRITIS

One of the most important postinfectious complications is:

Reactive arthritis

It typically develops after the gastrointestinal illness has begun to resolve.

Symptoms may include:

• Painful swollen joints

• Oligoarthritis

• Lower-extremity predominance

The arthritis is sterile.

Yersinia is one of the classic gastrointestinal triggers of reactive arthritis.

⸻

HLA-B27

Reactive arthritis is more likely and may be more severe in patients who are:

HLA-B27 positive.

This association is particularly high yield.

⸻

ANKYLOSING SPONDYLITIS

Rarely, Yersinia infection has been associated with later development or triggering of:

• Sacroiliitis

• Spondyloarthritis

• Ankylosing spondylitis

This association is strongest in genetically susceptible patients, particularly those with HLA-B27.

⸻

Infectious Disease and Microbiology - Yersinia enterocolitica Infections

Kembara Xtra

Archives

Categories